Stockscreener 앱 받기
0.00
100.00%
-47.98
전일 마감가:
$47.98
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$1.23B
수익:
-
순이익/손실:
$11.77M
주가수익비율:
0.00
EPS:
0.5785
순현금흐름:
$-19.23M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$48.27
Tourmaline Bio Inc Stock (TRML) Company Profile
명칭
Tourmaline Bio Inc
전화
646-481-9832
주소
27 WEST 24TH STREET, NEW YORK
TRML을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRML
Tourmaline Bio Inc
|
0.00 | 1.23B | 0 | 11.77M | -19.23M | 0.5785 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-23 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-06 | 개시 | Wedbush | Outperform |
| 2024-12-06 | 개시 | BMO Capital Markets | Outperform |
| 2024-11-11 | 재확인 | H.C. Wainwright | Buy |
| 2023-12-15 | 개시 | Jefferies | Buy |
| 2023-12-04 | 재개 | H.C. Wainwright | Buy |
| 2023-11-17 | 개시 | Truist | Buy |
| 2023-10-31 | 개시 | Guggenheim | Buy |
| 2023-10-25 | 개시 | Piper Sandler | Overweight |
| 2022-10-20 | 개시 | H.C. Wainwright | Buy |
| 2022-07-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
모두보기
Tourmaline Bio Inc 주식(TRML)의 최신 뉴스
Movement Recap: What catalysts could drive Tourmaline Bio Inc stock higherRate Cut & Precise Buy Zone Tips - BỘ NỘI VỤ
Can Tourmaline Bio Inc. stock outperform in 2025 bull marketEarnings Risk Summary & Daily Stock Trend Watchlist - moha.gov.vn
Will Tourmaline Bio Inc. stock outperform value stocksQuarterly Portfolio Review & Safe Swing Trade Setups - newser.com
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Is Tourmaline Bio Inc. stock attractive after correctionTrade Entry Summary & Verified Short-Term Plans - newser.com
How to manage a losing position in Tourmaline Bio Inc.Market Performance Summary & Fast Exit and Entry Trade Guides - newser.com
Will Tourmaline Bio Inc. stock reach all time highs in 2025Trade Performance Summary & Safe Swing Trade Setups - newser.com
Combining machine learning predictions for Tourmaline Bio Inc.Long Setup & Weekly Setup with ROI Potential - newser.com
How Tourmaline Bio Inc. stock performs in rate cut cyclesJuly 2025 PostEarnings & Verified Chart Pattern Signals - newser.com
Is Tourmaline Bio Inc. stock a top pick in earnings seasonAnalyst Downgrade & Smart Allocation Stock Tips - newser.com
[EFFECT] Tourmaline Bio, Inc. SEC Filing - Stock Titan
Using Bollinger Bands to evaluate Tourmaline Bio Inc.Portfolio Gains Report & Daily Technical Forecast Reports - newser.com
Tourmaline Bio Inc. recovery potential after sell offPortfolio Performance Report & Consistent Profit Focused Trading Strategies - newser.com
How institutional buying supports Tourmaline Bio Inc. stockJuly 2025 Momentum & Low Risk High Win Rate Stock Picks - Fundação Cultural do Pará
How to monitor Tourmaline Bio Inc. with trend dashboardsQuarterly Profit Review & Step-by-Step Swing Trade Plans - newser.com
Analyzing drawdowns of Tourmaline Bio Inc. with statistical toolsJobs Report & Precise Swing Trade Alerts - newser.com
Tourmaline Bio Inc.’s volatility index tracking explainedAnalyst Upgrade & Safe Investment Capital Preservation Plans - newser.com
Statistical indicators supporting Tourmaline Bio Inc.’s strength2025 Technical Overview & Weekly Watchlist for Hot Stocks - newser.com
Is Tourmaline Bio Inc. stock a smart buy before Fed meeting2025 Volatility Report & Real-Time Market Trend Scan - newser.com
Tourmaline Bio Inc (TRML) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):